glp-1 roche Announces Positive Topline Results from Phase II Study for Dual GLP-1/GIP Receptor Agonist Solve for GLP-1-related Skin Changes:

These trials showed that semaglutide resulted in an average body weight reduction ranging from 8.4% up to 17% from baseline weight among participants

Lancet (2017) 390:166475

Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: The Whitehall II study

Your doctor will know whether or not tirzepatide is safe for you

doi: 10.1136/gutjnl-2014-308778 32 DaousiC.CassonI

As an example, Black women living in more socially disadvantaged neighborhoods had significantly worse breast cancer survival compared to those living in the least disadvantaged neighborhoods, even after accounting for clinical and individual socioeconomic factors (23)